Company page

Nextcure, Inc.

Nextcure, Inc. is a public company traded under the ticker NXTC in the American market. The company has a market capitalization of approximately $17.25 million. Nextcure focuses on developing innovative therapies for cancer and autoimmune diseases.

NXTC:NASDAQUpdated September 11, 2026
Nextcure, Inc. logo
Ticker
NXTC:NASDAQ
Asset type
Stock
Market cap
$32.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD